NeueHealth, Inc. (NYSE:NEUE – Get Free Report) CEO George Lawrence Mikan III sold 16,803 shares of the firm’s stock in a transaction that occurred on Tuesday, December 17th. The shares were sold at an average price of $4.18, for a total transaction of $70,236.54. Following the completion of the transaction, the chief executive officer now directly owns 83,029 shares in the company, valued at approximately $347,061.22. The trade was a 16.83 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
NeueHealth Price Performance
Shares of NEUE stock opened at $4.06 on Thursday. The stock has a market cap of $33.64 million, a PE ratio of -0.08 and a beta of 0.78. The stock has a 50-day moving average of $5.15 and a 200-day moving average of $5.26. NeueHealth, Inc. has a one year low of $3.99 and a one year high of $16.59.
Analyst Upgrades and Downgrades
Separately, Royal Bank of Canada reduced their price target on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a research report on Monday, December 9th.
Institutional Inflows and Outflows
A number of institutional investors have recently bought and sold shares of NEUE. Partners Group Holding AG bought a new position in shares of NeueHealth during the third quarter worth $463,000. Deer Management Co. LLC acquired a new stake in NeueHealth during the 2nd quarter worth $5,436,000. NEA Management Company LLC bought a new position in NeueHealth during the second quarter worth about $14,834,000. Renaissance Technologies LLC acquired a new position in NeueHealth in the second quarter valued at about $312,000. Finally, Pathway Capital Management LP bought a new stake in shares of NeueHealth in the second quarter worth about $61,000. Institutional investors and hedge funds own 63.88% of the company’s stock.
NeueHealth Company Profile
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Read More
- Five stocks we like better than NeueHealth
- Trading Halts Explained
- 3 Most Upgraded Stocks Closing 2024: What’s Next?
- How to Invest in Biotech Stocks
- 3 Best Industrials Sector Picks for Long-Term Investors in 2025
- How to Start Investing in Real Estate
- ABM Industries Stock: A Dividend King at a Discount
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.